Atai Life Sciences Revenue 2020-2024 | ATAI
Atai Life Sciences revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Atai Life Sciences Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $20 |
| 2020 | $ |
| 2019 | $ |
| Atai Life Sciences Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $0 |
| 2024-03-31 | |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | |
| 2021-03-31 | $20 |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.196B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.044B | 12.73 |
| Quest Diagnostics (DGX) | United States | $17.232B | 17.67 |
| DaVita (DVA) | United States | $13.682B | 16.83 |
| Encompass Health (EHC) | United States | $9.661B | 23.76 |
| Chemed (CHE) | United States | $9.016B | 27.72 |
| Elanco Animal Health (ELAN) | United States | $7.079B | 15.91 |
| Option Care Health (OPCH) | United States | $5.374B | 26.40 |
| RadNet (RDNT) | United States | $5.127B | 121.63 |
| Amedisys (AMED) | United States | $3.164B | 22.63 |
| Astrana Health (ASTH) | United States | $2.775B | 39.26 |
| LifeStance Health (LFST) | United States | $2.655B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.370B | 28.78 |
| U.S Physical Therapy (USPH) | United States | $1.272B | 34.44 |
| Pennant (PNTG) | United States | $1.039B | 49.84 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.999B | 0.00 |
| Daxor (DXR) | United States | $0.043B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.027B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.015B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |